The impact of the USPSTF recommendation against screening: another take

A research letter from the epidemiologists and statisticians at the American Cancer Society has just been published in JAMA Oncology. The full text of the research letter is available on line. … READ MORE …

The politics of PSA testing

We continue to see a steady stream of articles in the cancer literature that appears to be designed to influence the thinking of the U.S. Preventive Services Task Force (USPSTF) as they reconsider the value of PSA testing in assessment of risk for prostate cancer. … READ MORE …

MRI scanning as a screening test for prostate cancer: data from a pilot study

A newly published study from the Sunnybrook group at the University of Toronto has investigated the possibility of MRI scanning as a method to screen men for risk of clinically significant prostate cancer. … READ MORE …

The systemic problems of the PCLO trial of PSA screening

A Letter to the Editor published in this week’s issue of the New England Journal of Medicine has, yet again, pointed out that the US-based PCLO trial was badly flawed and was never, in fact, a trial of screening against no screening. … READ MORE …

PCPC3 notes revisions to USPSTF research plan on PSA screening

PCPC3 — the patient-centered prostate cancer collaborative coalition — has just issued a statement about the revised research plan issued by the U.S. Preventive Services Task Force (USPSTF) in reassessing the value of PSA screening for risk of prostate cancer. … READ MORE …

Clinician characteristics affect likelihood of PSA testing in older men

A new article in JAMA Internal Medicine has quantified (to some extent) how characteristics of clinicians affect the probability of older men being given PSA tests within the Veterans Administration health system here in the US. … READ MORE …

And back to the screening controversy, yet again …

Four very recent articles and presentations have addressed issues relevant to the use of the PSA test in testing/screening for risk of prostate cancer. … READ MORE …